Internal Medicine, Endocrinology, Diabetes, & Metabolism · Galion, OH
NPI
1225007545
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
270 Portland Way S
Galion, OH, 44833
Phone (419) 462-4656
Groups this clinician bills Medicare through
Medicare paid, 2024
$17K
403 services
Medicare patients, 2024
115
Average age 69
Drug cost, 2024
$2.4M
5,077 prescriptions
Company payments, 2025
$80.1
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Todd M Darmody was code 99214 (office e&m - established), 162 times for 84 patients. In total Todd M Darmody billed 403 services in 6 codes, and Medicare paid $17K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 162 | 84 | $68.97 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 106 | 68 | $12.37 | $1,311 |
| 95251 Test - Miscellaneous | Facility | 73 | 39 | $25.15 | $1,836 |
| 99213 Office E&M - Established | Facility | 33 | 28 | $41.84 | $1,381 |
| 99203 Office E&M - New | Facility | 11 | 11 | $47.47 | $522 |
By year: 2022 $685 for 18 services; 2023 $4,526 for 80 services; 2024 $17K for 403 services.
Medicare prescription drug claims, 2024
In 2024, the drug Todd M Darmody prescribed most often to Medicare patients was Levothyroxine Sodium, with 644 prescriptions and refills. In total Todd M Darmody wrote 5,077 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 644 | 1,348 | 137 | $6,589 |
| Ozempic Semaglutide | 383 | 491 | 79 | $463K |
| Mounjaro Tirzepatide | 234 | 275 | 46 | $288K |
| Metformin Hcl Generic | 227 | 544 | 62 | $1,002 |
| Metformin Hcl Er Metformin Hcl | 217 | 506 | 67 | $2,671 |
| Trulicity Dulaglutide | 201 | 262 | 39 | $252K |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 197 | 244 | 35 | $152K |
| Jardiance Empagliflozin | 189 | 348 | 49 | $200K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 123 | 180 | 49 | $9,253 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 117 | 301 | 47 | $21K |
| Humalog Kwikpen U-200 Insulin Lispro | 111 | 209 | 30 | $343K |
| Insulin Lispro Generic | 100 | 122 | 29 | $9,970 |
| Testosterone Cypionate Generic | 92 | 103 | 15 | $2,377 |
| Tresiba Flextouch U-200 Insulin Degludec | 86 | 133 | 22 | $81K |
| Novolog Flexpen Insulin Aspart | 83 | 125 | 31 | $27K |
Brand drugs: 2,536 claims; generic drugs: 1,871 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Todd M Darmody $80.1 ($80.1 in general payments such as food, travel and fees) from 3 companies. The largest payer was Beta Bionics, Inc. with $40.55.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.